SCIASCIA, Savino

SCIASCIA, Savino  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 20 di 251 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autore(i) File
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends 2014 Bertolaccini, Maria Laura; Amengual, Olga; Andreoli, Laura; Atsumi, Tatsuya; Chighizola, Cecilia B.; Forastiero, Ricardo; de Groot, Philip; Lakos, Gabriella; Lambert, Marc; Meroni, Pierluigi; Ortel, Thomas L.; Petri, Michelle; Rahman, Anisur; Roubey, Robert; Sciascia, Savino; Snyder, Melissa; Tebo, Anne E.; Tincani, Angela; Willis, Rohan
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome 2021 Sciascia S.; Radin M.; Cecchi I.; Levy R.A.; Erkan D.
16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome 2020 de Jesus G.R.; Benson A.E.; Chighizola C.B.; Sciascia S.; Branch D.W.
A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response 2021 Rossi, Daniela; Sciascia, Savino; Cecchi, Irene; Saracco, Marta; Montabone, Erika; Modena, Vittorio; Pellerito, Raffaele; Carignola, Renato; Roccatello, Dario
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. 2012 Roccatello, D; Sciascia, S; Baldovino, S; Rossi, D
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 2017 Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 2015 Roccatello, Dario; Sciascia, Savino; Baldovino, Simone; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Di Simone, Debora; Simoncini, Matteo; Menegatti, Elisa
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 2012 Sciascia S; Roccatello D; Bertero MT; Di Simone D; Cosseddu D; Vaccarino A; Bazzan M; Rossi D; Garcia-Fernandez C; Ceberio L; Stella S; Menegatti E; Baldovino S.
Acute kidney injury associated with glomerular diseases 2019 Fenoglio R.; Sciascia S.; Baldovino S.; Roccatello D.
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort 2019 Radin M.; Sciascia S.; Erkan D.; Pengo V.; Tektonidou M.G.; Ugarte A.; Meroni P.; Ji L.; Belmont H.M.; Cohen H.; Ramires de Jesus G.; Branch D.W.; Fortin P.R.; Andreoli L.; Petri M.; Rodriguez E.; Rodriguez-Pinto I.; Knight J.S.; Atsumi T.; Willis R.; Gonzalez E.; Lopez-Pedrera R.; Rossi Gandara A.P.; Borges Gualhardo Vendramini M.; Banzato A.; Sevim E.; Barbhaiya M.; Efthymiou M.; Mackie I.; Bertolaccini M.L.; Andrade D.
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 2017 Radin, Massimo; Schreiber, K.; Costanzo, P.; Cecchi, I.; Roccatello, Dario; Baldovino, Simone; Bazzan, M.; Cuadrado, M. J.; Sciascia, Savino
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis 2021 Rossi, Daniela; Cecchi, Irene; Sciascia, Savino; Naretto, Carla; Alpa, Mirella; Roccatello, Dario
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients 2009 Heffler, E; Asero, R; Nebiolo, F; Pizzimenti, S; Sciascia, S; Badiu, I; Guida, G; Mistrello, G; Amato, S; Marchese, C; Rolla, G
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 2020 Sciascia S.; Radin M.; Cecchi I.; Fenoglio R.; De Marchi A.; Besso L.; Baldovino S.; Rossi D.; Miraglia P.; Rubini E.; Roccatello D.
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. 2013 Sciascia S;Sanna G;Murru V;Roccatello D;Khamashta MA;Bertolaccini ML
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection 2020 Trunfio mattia, Salvador elena, Cabodi daniela, Marinaro Letizia, Alcantarini chiara, Gaviraghi Alberto, Trentalange Alice, Lipani Filippo, Sciascia Savino, Roccatello Dario, Bonora Stefano, Di Perri Giovanni, Calcagno Andrea
Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome 2014 Sciascia, S.; Bertolaccini, M.L.
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab 2018 Sciascia, Savino*; Rubini, Elena; Radin, Massimo; Cecchi, Irene; Rossi, Daniela; Roccatello, Dario
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study 2019 Sciascia, Savino; Yazdany, Jinoos; Dall'Era, Maria; Fenoglio, Roberta; Radin, Massimo; Aggarwal, Ishita; Cuadrado, Maria J.; Schreiber, Karen; Barreca, Antonella; Papotti, Mauro; Roccatello, Dario
Antiphosphatidylserine/prothrombin antibodies in systemic lupus erythematosus. 2013 Bertolaccini ML;Sciascia S;Sanna G;Khamashta MA